Researchers Advocate for Harmonized NGS Panels to Advance Precision Oncology
Federico Pio Fabrizio, Associate Professor of Molecular Biology at the Department of Medicine and Surgery at Kore University of Enna, along with colleagues, has published a Viewpoint in JAMA Oncology titled 'Why Harmonizing NGS Panels Is the Missing Link in Precision Oncology – One Genome, Too Many Standards.' The article highlights significant disparities in genomic testing practices, including variations in laboratory infrastructure, expertise, financial resources, and reimbursement policies. These discrepancies influence the selection of Next-Generation Sequencing (NGS) panels and testing methods both within and across countries. Smaller centers, in particular, may be limited to hotspot panels, potentially overlooking crucial actionable alterations and denying patients access to targeted therapies or biomarker-driven clinical trials. The researchers emphasize that fully realizing the clinical potential of precision oncology requires standardized, reliable, and equitable access to genomic testing, with h...